similar methods are being used to test cures for macular degeneration – a far more common genetic disorder that causes blindness – and sickle cell disease

Already, the Food and Drug Administration is expecting huge growth in the genetic medicine arena. By 2020, the FDA has said it is bracing for upwards of 200 gene therapy applications per year.